ASBPW Aspire Biopharma Holdings, Inc. - Warrant
$0,02
Precio · May 19, 2026
Fundamentales a fecha de May 15, 2026
Rango 52S
$0–$1
0% of range
Calificación del Analista
—
Precio Objetivo
—
P/E (TTM)
—
ROE
306.1%
Margen de Beneficio Neto
-394725.1%
ASBPW Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.02
Capitalización Bursátil
—
P/E (TTM)
—
BPA (TTM)
$-16.38
Ingresos (TTM)
$6.2K
Rendimiento div.
—
ROE
306.1%
Deuda/Capital
—
Rango 52S
$0 – $1
ASBPW Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$6.2K
2025-12-31
→
2025-12-31
BPA
$-16.38
2024-12-31
→
2025-12-31
Flujo de caja libre
—
Márgenes
-394725.1%
2025-12-31
→
2025-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
ASBPW
Mediana de Pares
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
ASBPW
Mediana de Pares
Gross Margin (Margen Bruto)
-1.9%
—
Operating Margin (Margen Operativo)
-312017.0%
—
Net Profit Margin (Margen de Beneficio Neto)
-394725.1%
—
ROA
-3353.2%
—
ROE
306.1%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
ASBPW
Mediana de Pares
Current Ratio (Ratio corriente)
0.2
—
Quick Ratio (Ratio Rápido)
0.1
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
ASBPW
Mediana de Pares
Net Income YoY (Beneficio Neto interanual)
33.7%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
ASBPW
Mediana de Pares
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 |
|---|---|---|
| Revenue | $6.2K | |
| Cost of Revenue | $6.3K | |
| Gross Profit | $-116 | |
| R&D Expense | $923.9K | |
| SG&A Expense | $18M | |
| Operating Expenses | $19M | |
| Operating Income | $-19M | |
| Other Non-op | $-5M | |
| Pretax Income | $-24M | |
| Net Income | $-24M | |
| EPS (Diluted) | $-16.38 | |
| Shares (Basic) | 1,494,956 | |
| Shares (Diluted) | 1,494,956 | |
| EBITDA | $-19M |
Balance general 15
| Métrica | Tendencia | 2025 |
|---|---|---|
| Cash & Equivalents | $1M | |
| Inventory | $253.2K | |
| Prepaid Expense | $55.1K | |
| Current Assets | $1M | |
| Total Assets | $1M | |
| Accounts Payable | $1M | |
| Accrued Liabilities | $1M | |
| Current Liabilities | $8M | |
| Total Liabilities | $8M | |
| Common Stock | $12 | |
| Paid-in Capital | $21M | |
| Retained Earnings | $-27M | |
| Stockholders' Equity | $-6M | |
| Liabilities + Equity | $1M | |
| Shares Outstanding | 117,780 |
Flujo de Efectivo 4
| Métrica | Tendencia | 2025 |
|---|---|---|
| Stock-based Comp | $14M | |
| Operating Cash Flow | $-5M | |
| Financing Cash Flow | $6M | |
| Net Change in Cash | $1M |
Rentabilidad 7
| Métrica | Tendencia | 2025 |
|---|---|---|
| Gross Margin | -1.9% | |
| Operating Margin | -312017.0% | |
| Net Margin | -394725.1% | |
| Pretax Margin | -394725.1% | |
| EBITDA Margin | -312017.0% | |
| ROA | -3353.2% | |
| ROE | 306.1% |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 |
|---|---|---|
| Current Ratio | 0.2 | |
| Quick Ratio | 0.1 |
Eficiencia 2
| Métrica | Tendencia | 2025 |
|---|---|---|
| Asset Turnover | 0.0 | |
| Inventory Turnover | 0.0 |
Valoración (TTM) 2
| Métrica | Tendencia | 2025 |
|---|---|---|
| Revenue TTM | $6.2K | |
| Net Income TTM | $-24M |
Estado de resultados 16
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Revenue | $28.4K | $4.3K | $1.9K | |
| Cost of Revenue | $22.6K | $5.3K | $1.1K | |
| Gross Profit | $5.8K | $-1.0K | $884 | |
| R&D Expense | $296.7K | $100.0K | $207.9K | |
| SG&A Expense | $1M | $2M | $513.0K | |
| Operating Expenses | $2M | $2M | $1M | |
| Operating Income | $-2M | $-2M | $-1M | |
| Interest Income | $5.0K | · | · | |
| Other Non-op | $-2M | $-3M | $-705.0K | |
| Pretax Income | $-3M | · | · | |
| Net Income | $-3M | $-5M | $-2M | |
| EPS (Basic) | $-20.57 | · | $-0.04 | |
| EPS (Diluted) | $-20.57 | $-15.95 | $-0.04 | |
| Shares (Basic) | 156,685 | -44,163,740 | 49,525,970 | |
| Shares (Diluted) | 156,685 | -44,163,740 | 49,525,970 | |
| EBITDA | $-2M | · | $-1M |
Balance general 15
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $6M | $1M | $2M | |
| Inventory | $370.0K | $253.2K | $35.4K | |
| Prepaid Expense | $890.1K | $55.1K | $419.4K | |
| Current Assets | $7M | $1M | $2M | |
| Total Assets | $7M | $1M | $2M | |
| Accounts Payable | $857.9K | $1M | $1M | |
| Accrued Liabilities | $441.6K | $1M | $266.9K | |
| Current Liabilities | $3M | $8M | $14M | |
| Total Liabilities | $3M | $8M | $14M | |
| Common Stock | $17 | $353 | $5.0K | |
| Paid-in Capital | $34M | $21M | $11M | |
| Retained Earnings | $-30M | $-27M | $-23M | |
| Stockholders' Equity | $4M | $-6M | $-11M | |
| Liabilities + Equity | $7M | $1M | $2M | |
| Shares Outstanding | 167,470 | 3,533,408 | 49,525,970 |
Flujo de Efectivo 6
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Stock-based Comp | $13.4K | $0 | $0 | |
| Operating Cash Flow | $-3M | $-927.8K | $-1M | |
| Stock Issued | $9M | · | · | |
| Net Stock Activity | $9M | · | · | |
| Financing Cash Flow | $8M | $-16.5K | $3M | |
| Net Change in Cash | $5M | $-944.4K | $2M |
Rentabilidad 7
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Gross Margin | 20.3% | · | 45.5% | |
| Operating Margin | -5806.0% | · | -59015.8% | |
| Net Margin | -11367.0% | · | -95337.1% | |
| Pretax Margin | -11367.0% | · | · | |
| EBITDA Margin | -5806.0% | · | -59015.8% | |
| ROA | -71.0% | · | -40.8% | |
| ROE | 157.8% | · | 20.6% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Current Ratio | 2.3 | · | 0.2 | |
| Quick Ratio | 1.9 | · | 0.1 |
Eficiencia 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.1 | · | 0.1 |
Valoración (TTM) 5
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Net Income TTM | $-23M | · | $-21M | |
| Market Cap | $3.3K | · | · | |
| P/B | 0.0 | · | · | |
| P / Tangible Book | 0.0 | · | · | |
| P / Cash Flow | -0.0 | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $6.2K | — | — | — | — |
| Margen Bruto % | -1.9% | — | — | — | — |
| Margen Operativo % | -312017.0% | — | — | — | — |
| Beneficio neto | $-24M | $-1M | $4M | $3M | $-25.5K |
| EPS Diluido | $-16.38 | $-1.90 | — | — | — |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 0.2 | 0.0 | 0.2 | 3.6 | — |
| Ratio Rápido | 0.1 | — | — | 1.6 | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.